Products
Platform
Research
Market
Learn
Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | - | 1.93 |
NAV | ₹10.00 | ₹431.62 |
Fund Started | 10 Nov 2025 | 04 Jun 1999 |
Fund Size | - | ₹4082.13 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
-
1.93
NAV
₹10.00
₹431.62
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
-
₹4082.13 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | - | 1.33% |
3 Year | - | 24.51% |
5 Year | - | 20.32% |
1 Year
-
1.33%
3 Year
-
24.51%
5 Year
-
20.32%
Holding Analysis
Equity | 0.00% | 96.05% |
Cash | 0.00% | 3.88% |
Equity
0.00%
96.05%
Cash
0.00%
3.88%
Top Holdings
Top 10 Holdings | - |
|
Top 10 Holdings
-
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Fund Manager
Name | Viraj Kulkarni | Tanmaya Desai |
Start Date | 10 Nov 2025 | 17 May 2024 |
Name
Viraj Kulkarni
Tanmaya Desai
Start Date
10 Nov 2025
17 May 2024
About Fund
Description | The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 Nov 2025 | 04 Jun 1999 |
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999